These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2674531

  • 1. [Malignant testicular tumors in children. Concept of the cooperative therapy study MAHO 88 based on MAHO 82].
    Haas RJ, Göbel U, Harms D, Schmidt P, Weissbach L.
    Klin Padiatr; 1989; 201(4):269-74. PubMed ID: 2674531
    [Abstract] [Full Text] [Related]

  • 2. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Testicular germ cell tumors. Results of the GPO MAHO studies -82, -88, -92.
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1995; 207(4):145-50. PubMed ID: 7564144
    [Abstract] [Full Text] [Related]

  • 5. [Results of the cooperative Malignant Testicular Tumors 82 Study of the German Society of Pediatric Oncology on the therapy of malignant germ cell tumors in childhood].
    Haas RJ, Göbel U, Harms D, Schmidt P, Weissbach L.
    Klin Padiatr; 1988; 200(3):230-5. PubMed ID: 2463403
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Malignant testicular tumors in children and adolescents: concept of the MAHO 82 cooperative therapeutic study of the Society for Pediatric Oncology].
    Haas RJ, Brämswig J, Göbel U, Harms D, Janka G, Weissbach L.
    Klin Padiatr; 1983; 195(3):196-200. PubMed ID: 6192280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U, Bamberg M, Engert J, Gnekow AK, Haas HJ, Jürgens H, Kühl J, Lenard HG, Lumenta C, Niethammer D.
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology].
    Göbel U, Haas RJ, Harms D, Janka G, Brämswig J, Jürgens H, Weissbach L, Faber P, Müller E.
    Klin Padiatr; 1983; 195(3):201-6. PubMed ID: 6192281
    [Abstract] [Full Text] [Related]

  • 13. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 14. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 01; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Dec 01; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 16. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr 01; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D, Hornák M, Matoska J, Kausitz J, Belan V, Cársky S.
    Neoplasma; 1993 Apr 01; 40(4):247-53. PubMed ID: 7505886
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
    Krege S, Rübben H.
    Urologe A; 1993 May 01; 32(3):171-5. PubMed ID: 8390119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.